NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 197 filers reported holding NEVRO CORP in Q3 2021. The put-call ratio across all filers is 2.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,665,490 | -32.4% | 86,654 | -10.6% | 0.06% | -33.3% |
Q2 2023 | $2,464,444 | -1.8% | 96,949 | +39.6% | 0.09% | -11.4% |
Q1 2023 | $2,510,111 | +377.6% | 69,436 | +423.2% | 0.10% | +228.1% |
Q4 2022 | $525,532 | -86.6% | 13,271 | -85.1% | 0.03% | -77.6% |
Q2 2022 | $3,911,000 | +167.3% | 89,232 | +341.0% | 0.14% | +150.9% |
Q1 2022 | $1,463,000 | -63.6% | 20,232 | -59.2% | 0.06% | -68.5% |
Q4 2021 | $4,020,000 | +440.3% | 49,585 | +1005.3% | 0.18% | +277.1% |
Q2 2021 | $744,000 | -38.6% | 4,486 | -48.4% | 0.05% | -20.0% |
Q1 2021 | $1,212,000 | +415.7% | 8,687 | +538.8% | 0.06% | +500.0% |
Q4 2020 | $235,000 | -65.8% | 1,360 | -72.4% | 0.01% | -68.8% |
Q3 2020 | $687,000 | +101.5% | 4,929 | +72.7% | 0.03% | +88.2% |
Q2 2020 | $341,000 | -58.6% | 2,854 | -65.4% | 0.02% | -71.2% |
Q1 2020 | $824,000 | -85.9% | 8,241 | -83.4% | 0.06% | -77.0% |
Q4 2019 | $5,841,000 | +778.3% | 49,691 | +542.8% | 0.26% | +655.9% |
Q3 2019 | $665,000 | -1.8% | 7,730 | -26.0% | 0.03% | -8.1% |
Q2 2019 | $677,000 | +120.5% | 10,440 | +112.3% | 0.04% | +94.7% |
Q1 2019 | $307,000 | -52.7% | 4,918 | -70.5% | 0.02% | -63.5% |
Q4 2018 | $649,000 | +97.9% | 16,685 | +376.7% | 0.05% | +57.6% |
Q1 2017 | $328,000 | – | 3,500 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |